Dose Increase (0.5 mg to 1.0 mg): After four weeks, your dose may be increased to 0.5 mg, then potentially to 1.0 mg, depending on your response
Thank you VITAstir for being with me on my weight loss journey and maintenance
Empagliflozin is different from other medications in that it can be used to reduce the risk of death from heart attacks and strokes in patients with type 2 diabetes and heart disease
My joints are starting to be affected, though, so Id like to work on weight loss, but it feels impossible without my insurance covering something like this
Tang H, Lu Y, Okun MS, Donahoo WT, Ramirez-Zamora A, Wang F, Huang Y, Armstrong M, Svensson M, Virnig BA, DeKosky ST, Bian J, Guo J (2024) Glucagon-like Peptide-1 receptor agonists and risk of Parkinsons Disease in patients with type 2 diabetes: a Population-based Cohort Study